LiveDNA empowers researchers, scholars, editors, reviewers, publishers, and institutions with a trusted digital identity and comprehensive professional profile.
Chih-Hsuan  Hsia

Chih-Hsuan Hsia

LiveDNA ID: 886.30444
3 Publications
0 Editorial Roles
0 Projects

Education

Academic Background
  • Ph.D. Taipei Medical University, Taiwan Medicine | Completed: 2019

Publications (3)

Selected Scholarly Contributions
Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α II bβ3 binding in human platelets.
Hsia, C.H., W.J. Lu, K.H. Lin, D.S. Chou and P. Geraldine et al.,
J. Cell. Mol. Med., | Journal Article
Self Chih-Hsuan Hsia
2018
Novel iridium (III)‑derived organometallic compound for the inhibition of human platelet activation.
Shyu, K.G., M. Velusamy, C.W. Hsia, C.H. Yang and C.H. Hsia et al.,
Int. J. Mol. Sci., | Journal Article
Self Chih-Hsuan Hsia
2018
Development of benzimidazole derivatives as novel anti-platelet drugs.
Yao, W.C., L.T. Yuan, W.B. Yang, C.H. Hsia and L.T. Huang et al.,
Curr. Pharm. Biotechnol., | Journal Article
Self Chih-Hsuan Hsia
2017